Increased CFD is associated with worse progression-free survival in colorectal cancer [12] and promotes breast cancer growth and cancer stem cell-like properties [11], and CFD inhibitor is considered a highly sensitive and specific drug candidate in the therapy of cutaneous squamous cell carcinoma [13]. This evidence concerns the gene CFD and cutaneous squamous cell carcinoma.